欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FI/H/0449/001
药品名称Pamidronate Teva 3mg/ml
活性成分
    • pamidronic acid 3.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Teva Pharmaceuticals Europe B.V. Industrieweg 23 3641 RK Mijdrecht The Netherlands
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Germany (DE)
      Pamidronat GRY 3mg/ml
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
      PAMIDRONATO TEVA 3 mg/ml, concentrado para solución para perfusión
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
      Pamidronat Teva
    • Norway (NO)
    • Slovakia (SK)
      Pamidronate-Teva 3 mg/ml
许可日期2005/07/19
最近更新日期2020/04/20
药物ATC编码
    • M05BA03 pamidronic acid
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Bibliographic [Article 10.1(a)(ii)]
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase